Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

927.15

-19.95 (-2.11%)

< Home < Back

Zydus Lifesciences informs about press release

Date: 26-04-2025

Zydus Lifesciences has informed that it enclosed a copy of press release dated April 26, 2025, titled ‘Closure of USFDA inspection at Zydus’ API Unit at Dabhasa, Gujarat’.

The above information is a part of company’s filings submitted to BSE.